Abstract:Risk taking behavior is a symptom of multiple neuropsychiatric disorders and often lacks effective treatments. Reward circuitry regions including the amygdala, orbitofrontal cortex, insula, and anterior cingulate have been implicated in risk-taking by neuroimaging studies. Electrophysiological activity associated with risk taking in these regions is not well understood in humans. Further characterizing the neural signalling that underlies risk-taking may provide therapeutic insight into disorders associated with risk-taking. Eleven patients with pharmacoresistant epilepsy who underwent stereotactic electroencephalography with electrodes in the amygdala, orbitofrontal cortex, insula, and/or anterior cingulate participated. Patients participated in a gambling task where they wagered on a visible playing card being higher than a hidden card, betting $5 or $20 on this outcome, while local field potentials were recorded from implanted electrodes. We used cluster-based permutation testing to identify reward prediction error signals by comparing oscillatory power following unexpected and expected rewards. We also used cluster-based permutation testing to compare power preceding high and low bets in high-risk (<50% chance of winning) trials and two-way ANOVA with bet and risk level to identify signals associated with risky, risk averse, and optimized decisions. We used linear mixed effects models to evaluate the relationship between reward prediction error and risky decision signals across trials, and a linear regression model for associations between risky decision signal power and Barratt Impulsiveness Scale scores for each patient. Reward prediction error signals were identified in the amygdala (p=0.0066), anterior cingulate (p=0.0092), and orbitofrontal cortex (p=6.0E-4, p=4.0E-4). Risky decisions were predicted by increased oscillatory power in high-gamma frequency range during card presentation in the orbitofrontal cortex (p=0.0022), and by increased power following bet cue presentation across the theta-to-beta range in the orbitofrontal cortex ( =0.0022), high-gamma in the anterior cingulate ( =0.0004), and high-gamma in the insula ( =0.0014). Risk averse decisions were predicted by decreased orbitofrontal cortex gamma power ( =2.0E-4). Optimized decisions that maximized earnings were preceded by decreases within the theta to beta range in orbitofrontal cortex ( =2.0E-4), broad frequencies in amygdala ( =2.0E-4), and theta to low-gamma in insula ( =4.0E-4). Insula risky decision power was associated with orbitofrontal cortex high-gamma reward prediction error signal ( =0.0048) and with patient impulsivity ( =0.00478). Our findings identify and help characterize reward circuitry activity predictive of risk-taking in humans. These findings may serve as potential biomarkers to inform the development of novel treatment strategies such as closed loop neuromodulation for disorders of risk taking.

Anticonvulsant medications attenuate amphetamine-induced deficits in behavioral inhibition but not decision making under risk on a rat gambling task

Serotonergic and Dopaminergic Modulation of Gambling Behavior As Assessed Using a Novel Rat Gambling Task.

Impulsive Behaviour Induced by Both NMDA Receptor Antagonism and GABAA Receptor Activation in Rat Ventromedial Prefrontal Cortex

Affective and cognitive mechanisms of risky decision making

Methylphenidate, but not citalopram, decreases impulsive choice in rats performing a temporal discounting task

Selective and Interactive Effects of D2 Receptor Antagonism and Positive Allosteric Mglur4 Modulation on Waiting Impulsivity.

Enhanced Prefrontal Function with Pharmacotherapy on a Response Inhibition Task in Adolescent Bipolar Disorder.

Activation of the mPFC-NAc pathway reduces motor impulsivity but does not affect risk-related decision-making in innately high-impulsive rats

Interactions Between Serotonin and Dopamine in the Control of Impulsive Choice in Rats: Therapeutic Implications for Impulse Control Disorders

Reward Circuit Local Field Potential Modulations Precede Risk Taking

Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers

Dissociable roles of the mPFC-to-VTA Pathway in the control of iImpulsive Action and Risk-Related Decision-Making in Roman High- And Low-Avoidance Rats

Circuit and Cell-Specific Contributions to Decision Making Involving Risk of Explicit Punishment in Male and Female Rats

Decision-Making by Patients With Methamphetamine Use Disorder Receiving Contingency Management Treatment: Magnitude and Frequency Effects

Pramipexole restores behavioral inhibition in highly impulsive rats through a paradoxical modulation of frontostriatal networks

D2/3 Agonist during Learning Potentiates Cued Risky Choice

Impact of Cannabinoid Type 1 Receptor Modulation on Risky Decision-Making

‘Waiting Impulsivity’ in Isolation-Reared and Socially-Reared Rats: Effects of Amphetamine

Modulation of High Impulsivity and Attentional Performance in Rats by Selective Direct and Indirect Dopaminergic and Noradrenergic Receptor Agonists

Dissociable Control of Impulsivity in Rats by Dopamine D2/3 Receptors in the Core and Shell Subregions of the Nucleus Accumbens

Atomoxetine Reduces Decisional Impulsivity in Human Cocaine Addiction